Evidence map›Paper›PMID 32606212›Full record

Trial reportBMJ quality & safety2021

User-testing guidelines to improve the safety of intravenous medicines administration: a randomised in situ simulation study.

Matthew D Jones, Anita McGrogan, D K Raynor, Margaret C Watson, Bryony Dean Franklin

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ quality & safety, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Matthew D JonesDepartment of Pharmacy and Pharmacology, University of Bath, Bath, UK M.D.Jones@bath.ac.uk.ORCID 0000-0002-2617-4098
Anita McGroganDepartment of Pharmacy and Pharmacology, University of Bath, Bath, UK.ORCID 0000-0003-3855-9400
D K RaynorSchool of Healthcare, University of Leeds, Leeds, UK.ORCID 0000-0003-0306-5275
Margaret C WatsonDepartment of Pharmacy and Pharmacology, University of Bath, Bath, UK.ORCID 0000-0002-8198-9273
Bryony Dean FranklinCentre for Medication Safety and Service Quality, Imperial College Healthcare NHS Trust, London, UK.ORCID 0000-0002-2892-1245
University of Bath · GBImperial College Healthcare NHS Trust · GBUniversity of Leeds · GBUniversity of Strathclyde · GB

Funding

Department of Health TRF-2017-10-006
6 · The paper itself

Abstract

backgroundUser-testing and subsequent modification of clinical guidelines increases health professionals' information retrieval and comprehension. No study has investigated whether this results in safer care.

objectiveTo compare the frequency of medication errors when administering an intravenous medicine using the current National Health Service Injectable Medicines Guide (IMG) versus an IMG version revised with user-testing.

methodSingle-blind, randomised parallel group in situ simulation. Participants were on-duty nurses/midwives who regularly prepared intravenous medicines. Using a training manikin in their clinical area, participants administered a voriconazole infusion, a high-risk medicine requiring several steps to prepare. They were randomised to use current IMG guidelines or IMG guidelines revised with user-testing. Direct observation was used to time the simulation and identify errors. Participant confidence was measured using a validated instrument. The primary outcome was the percentage of simulations with at least one moderate-severe IMG-related error, with error severity classified by an expert panel.

resultsIn total, 133 participants were randomised to current guidelines and 140 to user-tested guidelines. Fewer moderate-severe IMG-related errors occurred with the user-tested guidelines (n=68, 49%) compared with current guidelines (n=79, 59%), but this difference was not statistically significant (risk ratio: 0.82; 95% CI 0.66 to 1.02). Significantly more simulations were completed without any IMG-related errors with the user-tested guidelines (n=67, 48%) compared with current guidelines (n=26, 20%) (risk ratio: 2.46; 95% CI 1.68 to 3.60). Median simulation completion time was 1.6 min (95% CI 0.2 to 3.0) less with the user-tested guidelines. Participants who used user-tested guidelines reported greater confidence.

conclusionUser-testing injectable medicines guidelines reduces the number of errors and the time taken to prepare and administer intravenous medicines, while increasing staff confidence. TRIAL REGISTRATION NUMBER: researchregistry5275.

Indexed as

Infusions, IntravenousState MedicineAdultFemaleHumansMaleSingle-Blind Methodclinical practice guidelinesmedication safetynursespatient safety

Identifiers

PMID32606212
PMCPMC7788229
OpenAlexW3034687330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.